Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 400 of 741 entries
View as:

Aspirin and Clopidogrel Reactivity in Patients With Critical Limb Ischemia (CLI)

Phase: N/A Priority: Normal
NCT ID: NCT02094755 Org: User:
Start: 06/19/13 End: 01/31/17 Due: 01/31/18

Healthy Eating Through Reduction Of Excess Sugar

Phase: N/A Priority: Normal
NCT ID: NCT02948647 Org: User:
Start: 11/30/16 End: 11/30/21 Due: 11/30/22

Reducing the Duration of Untreated Psychosis

Phase: N/A Priority: Normal
NCT ID: NCT03102151 Org: User:
Start: 05/31/14 End: 08/30/19 Due: 08/30/20

Evaluating a Mobile Phone Intervention

Phase: N/A Priority: Normal
NCT ID: NCT04554706 Org: User:
Start: 05/06/21 End: 11/06/21 Due: 11/06/22

A Dose Finding Phase 1 of Sarilumab Plus Capecitabine in HER2/Neu-Negative Metastatic Breast Cancer and a Single-arm, Historically-controlled Phase 2 Study of Sarilumab Plus Capecitabine in Stage I-III Triple Negative Breast Cancer With High-Risk Residual Disease (EMPOWER)

Phase: N/A Priority: Normal
NCT ID: NCT04333706 Org: User:
Start: 09/26/20 End: 09/01/27 Due: 09/01/28

Cryoablation for Benign Gastrointestinal Anastomotic Strictures

Phase: N/A Priority: Normal
NCT ID: NCT04372784 Org: User:
Start: 09/30/20 End: 12/31/22 Due: 12/31/23

Doxorubicin (Doxil) Combined With Rituxan, Cyclophosphamide, Vincristine and Prednisone in Newly Diagnosed Aggressive Non-Hodgkin's Lymphomas

Phase: N/A Priority: Normal
NCT ID: NCT00184002 Org: User:
Start: 01/10/03 End: 05/07/13 Due: 05/07/14

Combination Chemotherapy and Bevacizumab With or Without PRI-724 in Treating Patients With Newly Diagnosed Metastatic Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02413853 Org: User:
Start: 11/30/15 End: 11/30/18 Due: 11/30/19

Video Messages and Vaccination Intention

Phase: N/A Priority: Normal
NCT ID: NCT04979416 Org: User:
Start: 07/21/21 End: 07/22/21 Due: 07/22/22

Study of Gemcitabine and Concurrent Radiation Followed by Adjuvant Hysterectomy in Bulky Stage Ib and IIa Cervical Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT00184093 Org: User:
Start: 06/30/99 End: 05/31/09 Due: 05/31/10

Helping Hypertension Patients to Interpret Blood Pressure Readings and Motivate Blood Pressure Control

Phase: N/A Priority: Normal
NCT ID: NCT04485637 Org: User:
Start: 03/23/22 End: 04/05/22 Due: 04/05/23

Psychosocial Outcomes in Hand Therapy

Phase: N/A Priority: Normal
NCT ID: NCT03458013 Org: User:
Start: 05/01/18 End: 01/22/20 Due: 01/22/21

Dose Optimization for Stroke Evaluation

Phase: N/A Priority: Normal
NCT ID: NCT01749358 Org: User:
Start: 03/31/12 End: 08/31/16 Due: 08/31/17

Cefixime Clinical Trial

Phase: N/A Priority: Normal
NCT ID: NCT04958122 Org: User:
Start: 06/20/21 End: 06/30/27 Due: 06/30/28

A2-ESO-1 TCR-Engineered T Cells for Relapsed/Refractory Advanced or Metastatic NY-ESO-1 Overexpression Positive Triple Negative Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05989828 Org: User:
Start: 12/17/24 End: 12/17/27 Due: 12/17/28

Lavender Aromatherapy for Anxiety During Urodynamics

Phase: N/A Priority: Normal
NCT ID: NCT02344745 Org: User:
Start: 10/31/14 End: 08/31/15 Due: 08/31/16

El Sendero: Pathways to Health Study

Phase: N/A Priority: Normal
NCT ID: NCT05551650 Org: User:
Start: 09/01/21 End: 08/31/25 Due: 08/31/26

Vaccine Therapy With or Without Interleukin-12 in Treating Patients With Stage III or Stage IV Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT00003339 Org: User:
Start: 11/30/98 End: 09/30/04 Due: 09/30/05

Intensified Post Remission Therapy Containing PEG-Asparaginase

Phase: N/A Priority: Normal
NCT ID: NCT00184041 Org: User:
Start: 07/31/04 End: 12/31/12 Due: 12/31/13

Keck Medicine of University of Southern California Thrive Study

Phase: N/A Priority: Normal
NCT ID: NCT05780892 Org: User:
Start: 04/12/23 End: 06/30/25 Due: 06/30/26

Linezolid for Syphilis Pilot Study

Phase: N/A Priority: Normal
NCT ID: NCT05548426 Org: User:
Start: 09/28/23 End: 03/31/26 Due: 03/31/27

Vascularized Composite Bladder Allograft Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT05462561 Org: User:
Start: 05/01/23 End: 05/01/26 Due: 05/01/27

Physical Activity and Social Support Prompting Via Phone Messaging

Phase: N/A Priority: Normal
NCT ID: NCT02850770 Org: User:
Start: 04/30/15 End: 11/30/15 Due: 11/30/16

A Study of Irinotecan, Cisplatin and Celebrex in Patients With Metastatic or Unresectable Esophageal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00183807 Org: User:
Start: 10/31/03 End: 03/31/08 Due: 03/31/09

The Femtosecond Laser in Residency Training (FLIRT) Pilot Study

Phase: N/A Priority: Normal
NCT ID: NCT03115216 Org: User:
Start: 07/31/17 End: 07/31/18 Due: 07/31/19